Romanian Society of Pharmaceutical Sciences

« Back to Farmacia Journal 4/2014

COMPARATIVE STUDY REGARDING CELIPROLOL AND METOPROLOL USE IN THE TREATMENT OF ESSENTIAL ARTERIAL HYPERTENSION

SORINA LIVIA POP1*, CODRUȚA MĂRGINEAN1, SIMONA MIREL2, DANIEL MUREȘAN1, DANIELA POP VORNICESCU1, RAREȘ GHERMAN1, EMIL ONACĂ1

“Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca
1.Faculty of Medicine
2.Faculty of Pharmacy

Download Full Article PDF

The effects of β–blockers in essential arterial hypertension (EAHT) are well known. The main objective of our study was to study comparatively the efficacy and the safety of the administration of two representatives of this class: celiprolol versus metoprolol, in equivalent doses, over a 2 weeks period. Unlike metoprolol, celiprolol is a cardioselective beta 1-blocker, with a moderate intrinsic beta 2-sympathomimetic action and minimal vasodilatatory effects. Metoprolol and celiprolol were initially administered in doses of 6.25 mg twice a day and 50 mg a day, respectively; the doses were increased every 3 days, under careful clinical monitoring, up to 50 mg twice a day and 200 mg a day, respectively, a normalization of blood pressure values being obtained. We also monitored the occurrence of the most frequent side effects of beta-blockers: bradycardia, fatigue, cold extremities. Only minor side effects were registered, which did not require the suppression of treatment. No significant changes in laboratory tests were found.